Programmed Death 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Gene Expression in Peripheral Blood Mononuclear Cells Can Serve as Prognostic Biomarkers for Hepatocellular Carcinoma

• Published in: Cancers 2024-04, Vol.16 (8), p.1493
• Main Authors: Lee, Ji Ah, Choi, Hei-Gwon, Eun, Hyuk Soo, Bu, Jiyoon, Jang, Tae Min, Lee, Jeongdong, Son, Chae Yeon, Kim, Min Seok, Rou, Woo Sun, Kim, Seok Hyun, Lee, Byung Seok, Kim, Ha Neul, Lee, Tae Hee, Jeon, Hong Jae
• Format: Article
• Language: English
• Subjects: Antigens; Apoptosis; Ascites; Biobanks; Biomarkers; Cancer therapies; Cell death; Clinical outcomes; CTLA-4 protein; Cytotoxicity; Disease; Gene amplification; Gene expression; Hepatocellular carcinoma; Hospitals; Immunotherapy; Leukocytes (mononuclear); Liver cancer; Lymphocytes T; Malignancy; Medical prognosis; Metastases; Patients; PD-1 protein; Peripheral blood mononuclear cells; Prognosis; Proteins; Tumors
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers16081493

Hepatocellular carcinoma (HCC) is a highly aggressive form of liver cancer with poor prognosis. The lack of reliable biomarkers for early detection and accurate diagnosis and prognosis poses a significant challenge to its effective clinical management. In this study, we investigated the diagnostic and prognostic potential of programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) expression in peripheral blood mononuclear cells (PBMCs) in HCC. PD-1 and CTLA-4 gene expression was analyzed comparatively using PBMCs collected from HCC patients and healthy individuals. The results revealed higher PD-1 gene expression levels in patients with multifocal tumors, lymphatic invasion, or distant metastasis than those in their control counterparts. However, conventional serum biomarkers of liver function do not exhibit similar correlations. In conclusion, PD-1 gene expression is associated with OS and PFS and CTLA-4 gene expression is associated with OS, whereas the serum biomarkers analyzed in this study show no significant correlation with survival in HCC. Hence, PD-1 and CTLA-4 expressed in PBMCs are considered potential prognostic biomarkers for patients with HCC that can facilitate prediction of malignancy, response to currently available HCC treatments, and overall survival.